Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Whistler Medical Marijuana was a Canadian medical cannabis company and licensed producer based in British Columbia, known for premium organic cannabis cultivated in soil and processed in small-batch formats. The company focused on commercial production and sale of medical cannabis products rather than a traditional drug-development pipeline. Whistler built a reputation around organic-certified cannabis, hand-crafted cultivation practices, and premium dried flower and derivative products for medical patients. Aurora Cannabis acquired the company in an all-share transaction that closed on March 1, 2019, and the Whistler/WMMC brand has since continued within Aurora’s medical cannabis portfolio. The former Whistler site in Pemberton, British Columbia was later upgraded by Aurora and renamed Aurora Alpine in 2025.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Whistler Medical Marijuana Company.